Early targeted patent ductus arteriosus treatment in premature neonates using a risk based severity score: study protocol for a randomised controlled trial (PDA RCT) [version 1; peer review: 2 approved]

Early targeted patent ductus arteriosus treatment in premature neonates using a risk based severity score: study protocol for a randomised controlled trial (PDA RCT) [version 1; peer review: 2 approved]

A patent ductus arteriosus (PDA) in preterm infants is associated with increased ventilator dependence and chronic lung disease, necrotizing enterocolitis, intraventricular haemorrhage, and poor neurodevelopmental outcome. Randomised controlled trials of early PDA treatment have not established a dr...

Full description

Bibliographic Details
Main Authors: Afif EL-Khuffash, Neidin Bussmann, Colm R. Breatnach, Aisling Smith, Elizabeth Tully, Joanna Griffin, Naomi McCallion, John David Corcoran, Elena Fernandez, Claudia Looi, Brian Cleary, Orla Franklin, Patrick J. McNamara
Format: Article
Language:English
Published: F1000 Research Ltd 2020-11-01
Series:HRB Open Research
Online Access:https://hrbopenresearch.org/articles/3-87/v1

Internet

https://hrbopenresearch.org/articles/3-87/v1

Similar Items